Ditchcarbon
  • Contact
  1. Organizations
  2. Bachem Holding AG
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated a month ago

Bachem Holding AG Sustainability Profile

Company website

Bachem Holding AG, a leading global player in the biotechnology sector, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1971, Bachem has established itself as a pioneer in the development and production of peptide-based active pharmaceutical ingredients (APIs) and innovative drug delivery systems. The company’s core offerings include high-quality peptides and complex organic molecules, which are distinguished by their exceptional purity and reliability. Bachem's commitment to quality and sustainability has earned it a prominent position in the pharmaceutical and biotech industries, with notable achievements in custom synthesis and contract manufacturing. As a trusted partner for major pharmaceutical companies, Bachem continues to drive advancements in therapeutic solutions, solidifying its reputation as a leader in peptide chemistry.

DitchCarbon Score

How does Bachem Holding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Bachem Holding AG's score of 18 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Bachem Holding AG's reported carbon emissions

Bachem Holding AG, headquartered in Switzerland, is committed to addressing climate change through various initiatives, although specific carbon emissions data is currently unavailable. The company has made a commitment to near-term science-based targets, indicating a proactive approach to reducing its carbon footprint. As part of the pharmaceuticals, biotechnology, and life sciences sector, Bachem is focused on aligning its operations with industry standards for sustainability. While the company has not set a net-zero target, it is actively engaged in climate commitments, as evidenced by its participation in the Science Based Targets initiative (SBTi). Bachem's climate strategy reflects a commitment to transparency and accountability in its environmental impact, although further details on specific reduction targets or achievements are not provided at this time. The absence of emissions data suggests that the company may still be in the process of establishing comprehensive reporting mechanisms. Overall, Bachem Holding AG is taking steps towards climate responsibility, with a focus on future emissions reduction and sustainability within its operational framework.

How Carbon Intensive is Bachem Holding AG's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Bachem Holding AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Bachem Holding AG's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Bachem Holding AG is in CH, which has a very low grid carbon intensity relative to other regions.

Bachem Holding AG's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Bachem Holding AG has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Bachem Holding AG's Emissions with Industry Peers

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 10 days ago

Sartorius

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated about 11 hours ago

Catalent

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Celerion Inc.

US
•
Health and social work services (85)
Updated about 1 month ago

Genentech

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy